Serum calprotectin a potential biomarker in juvenile idiopathic arthritis: A meta-analysis

E Altobelli, PM Angeletti, R Petrocelli… - Journal of Clinical …, 2021 - mdpi.com
Juvenile idiopathic arthritis (JIA) is the most common inflammatory chronic disease affecting
children and adolescents. Today, there are no specific biomarkers of inflammation …

Effects of lumacaftor-ivacaftor on airway microbiota-mycobiota and inflammation in patients with cystic fibrosis appear to be linked to Pseudomonas aeruginosa …

R Enaud, F Lussac-Sorton, E Charpentier… - Microbiology …, 2023 - Am Soc Microbiol
Lumacaftor-ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR)
modulator combination approved for patients with cystic fibrosis (CF) who are homozygous …

Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post …

SL Smith, S Alexander, N Nair, S Viatte… - Annals of the …, 2023 - ard.bmj.com
Objectives The inflammatory protein calprotectin (MRP8/14) has been identified as a
promising biomarker of treatment response in rheumatoid arthritis (RA). Our aim was to test …

Serum calprotectin levels in different subtypes of Juvenile idiopathic arthritis (JIA) and its correlation with quantitative CRP and JADAS-27

F Remthangpuii, A Maheshwari, S Gulati… - Indian Journal of …, 2023 - Springer
Objective To study the serum calprotectin levels in children with juvenile idiopathic arthritis
(JIA) and correlate it with C-reactive protein (CRP) and the Juvenile Arthritis Disease Activity …

[PDF][PDF] Calprotectin (S100A8/A9) as a marker of inflammation and treatment monitoring in cases of Juvenile Idiopathic Arthritis in the Western Cape, South Africa

C Evert - 2023 - scholar.sun.ac.za
Abstract Background: Juvenile Idiopathic Arthritis (JIA) is a common rheumatic disease
affecting children and is characterised by persistent inflammation of the joints. The socio …

Microbiome et inflammation pulmonaires et digestifs dans la mucoviscidose: Approches physiopathologiques et thérapeutiques

R Enaud - 2021 - theses.hal.science
L'étude du myco-microbiote et de l'inflammation est un élément clé de la compréhension
physiopathologiques des atteintes respiratoires et intestinales de la mucoviscidose, mais …